HTA Quarterly | Fall 2018

By Xcenda |

In this issue, we examine the wearable technology big data revolution from a global perspective, the innovative strategies to provide access for CAR-T therapies, and the considerations for market access in Catalonia. 

Heard on the Street

“The administration is imposing foreign price controls from countries with socialized health care systems that deny their citizens access and discourage innovation. The proposed Medicare Part B model would jeopardize access to medicines for seniors and patients with disabilities living with devastating conditions such as cancer, rheumatoid arthritis, and other autoimmune diseases.”

– Stephen J. Ubl, president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA) regarding President Trump’s Medicare Part B reform which would implement an International Pricing Index (IPI) payment model.
Industry Groups Fire Back as Trump Proposes Cutting Part B Medicare Drug Costs

HTA by the Numbers

HTA Decision Map

Find detailed information on product decisions in Australia, Canada, France, Germany, and the United Kingdom with our HTA Decision Map.
Map of Europe